[2] [5] Ozempic (semaglutide) and Mounjaro (tirzepatide) are FDA-approved for type 2 diabetes management, not weight loss, though they may be used off-label for this purpose
The Nordic Cochrane Centre, Copenhagen, 2020
Hair loss has been reported by some patients on GLP-1 therapy, likely related to rapid weight loss and nutritional changes rather than a direct drug effect
Quite often though, a patient with B12 deficiency experiences symptoms getting worse before better when treatment with B12 injections start -so it can take a while to feel improvements
Heres what most people notice with consistent use: Skin glow & freshness: 34 weeks Texture and smoothness: 68 weeks Results vary depending on lifestyle, hydration, skincare routine, and overall health
To manage this, try eating smaller meals more frequently, staying hydrated with electrolytes, and avoiding fatty or spicy foods